Yael Kusne

Yael Kusne is a member of the class of 2018. She completed her PhD in Neuroscience prior to starting medical school at ASU/BNI where she studied the complex signaling mechanisms of glioblastoma. Her passion lies in finding ways to incorporate research and medicine. She has four rescue dogs (yes, four) -- who she loves more than life and thinks of as her children.

Research, ScienceJuly 4, 2015

TMIS | Evolocumab + Dr. Haussler

By Yael Kusne

This month in science…

We learned that evolocumab, a monoclonal antibody inhibiting proprotein convertase subtilisin-kexin type 9 (PCSK9), reduces low-density lipoprotein (LDL) cholesterol levels.